Wednesday, January 19, 2011  |  Volume 3/Number 1  |  A Production of the BioProcessing Journal
Only 4 Exhibit Booths Left
-
ISBioTech
1st Annual Meeting

April 4-6, 2011
-
Exhibit BoothsOnly four open booth spaces remain, so please contact us now if you would like to exhibit.
-
Workshop Time Slots
All time slots have been taken or are on hold, but we can put you on a waiting list for any spaces that might become available. Please submit an abstract immediately if you are interested.
-
-
BPJ Now in Production
-
The Winter 2010/2011
issue is available for
viewing online.
-
Click here for a preview.
-
-
Publish your article in time for the ISBioTech 2011 meeting. Contact us now!
-
-
Career Development
-
ISBioTech members
receive a 10% discount
off the registration fee
-
-
Email Phacilitate for details
-
-
-
-
-
New Brunswick Scientific has paired up with Pall Life Sciences to offer a series of forums designed to offer the newest techniques for improving quality and yield in drug development and production.
-
The traveling road shows expand New Brunswick’s repertoire of fermentor and bioreactor training programs, which range from intensive university-based wet-workshops to teach practical fermentor and bioreactor operation, to individual or group training programs held at your facility or New Brunswick Scientific’s in-house labs.
-
Click here to learn more.
-
-
-
Protein Expression
in Animal Cell
Conference (PEACe)

-
September 25-29, 2011
Cascais, Portugal
-
-
Suggested Reading
Hydrolytic Enzyme Production by Aspergillus niger in
Solid State Fermentation: Stimulation of Transcriptional
Regulation Through Carbon and Nitrogen Supplementation
By Shauna M. McKelvey and Richard A. Murphy
Alltech Biotechnology Centre
Novel Automated Micro-Scale Bioreactor Technology:
A Qualitative and Quantitative Mimic for Early Process Development
By Gareth Lewis1, Richard Lugg1, Ken Lee2, and Richard Wales2
1. MedImmune   2. The Automation Partnership
2010 Biological License Application Supplement - Noteworthy Approvals
This list reflects information regarding the supplements as of the approval date. It is not updated with regard to applicant or application status changes. The supplements are listed by date of approval, with the most recent action at the top. (Biological approvals by years 1996 through 2009 are also shown.)
A Blog From the Editor
-
As we plunge into 2011, I can’t help but wonder it things will ever return to some semblance of normalcy. Acquisitions continue at a frightening pace, when what we really need is for things to stabilize and small companies to find more productive avenues to sustainability. Remember when contract research, and a firm’s ability to license both manufacturing and marketing rights, could provide a viable business plan? The big companies didn’t have to buy organizations to get the products they wanted, and Wall Street was still in the business of doing IPOs.
-
In December, it was so refreshing to visit a small company that was prospering with investments from a university, a large pharma, and a fairly unique private equity firm that actually wanted to build a company. This company had the necessary support to defend its patents, sufficient cash flow to grow, and the ability to pursue licensing and partnership arrangements with essentially anyone it wanted. Doesn’t this sound far better than being acquired?
-
Keith L. Carson – ChE, MBA, Editor in Chief
-
ISBioTech Annual Meeting (April 4-6, 2011)
-
Programs for the four parallel application tracks are complete, and several new sponsors and exhibits have been added. Plus a number of presentations on single-use components, systems and connectors are being organized into workshop sessions on Monday. A very strong session on cryopreservation will now complement the Antibody & Recombinant Protein track. and the program will feature plenary sessions on Contaminant Detection & Prevention and Quality By Design. For more information, go to www.isbiotech.org.
-
-
Baculovirus Reference Material
-
A working group has been formed to develop a baculovirus reference material. The group first met during an August 2010 workshop in Kuopio, Finland where they established a number of key parameters and guidelines.
-
Subsequent meetings will include face-to-face meetings at the ISBioTech 1st Annual Meeting in April 2011, and the 10th PEACe Conference in September 2011. Known for its work on the Ad5 and AAV2 reference materials, ISBioTech has been asked to help coordinate, facilitate, and mediate the group’s activities and decisions, plus host all documentation on its website.
-
A number of applications for baculovirus technology could benefit from a reference material including VLP vaccines, AAV production, and a wide array of antigens for vaccines, in-process reagents, and high-throughput screening. For more information, contact Amine Kamen at Amine.Kamen@cnrc-nrc.gc.ca or Keith Carson at kcarson@isbiotech.org.
-
-
Sponsored Links
-
8th Annual Biopharmaceutical Manufacturing Report and Survey
-
Time is running out for you to contribute to this valuable report from BioPlan Associates.
Over 400 individuals responded last year, so if you are working in a biomanufacturing or supply company, please take a few minutes to complete this survey at the following link: Biomanufacturing Survey. All responses are kept confidential, and you will receive a FREE summary of the results for contributing your input. Contact BioPlan Associates with any questions.
-
-
-
-
FOSS NIRSystems has introduced Service Pack 6 for its Vision 3.50 software, and the new ProFoss diode-array instrument has been added which includes support for self-test, diagnostics, data acquisition, and routine analysis. Vision is 21 CFR Part 11 compliant and supports PAT through numerous process analysis options and process communication capabilities. The software has an extensive security system with multiple access levels, as well as secure data archiving for reports and spreadsheets, plus database analysis. Email info@foss-nirsystems.com or visit their website.
-
Techno-Blast Masthead
-
Courtesy of Michael W. Davidson and the National High Magnetic Field Laboratory,
The Florida State University, Tallahassee (and featured on the Fall 2009 BioProcessing Journal cover)
-
DESCRIPTION: Madin-Darby Ovine Kidney Epithelial Cells (MDOK Line). Click here for full details.
Send us your cell image(s) today.
-
Advertising & Media
View Techno-Blast ad specifications by clicking here, and then contact us for pricing. And don't finalize your media plans for 2011 without consulting our new media kit! Email sales@isbiotech.org.